ID

20231

Descripción

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Blood Pressure: Seated blood pressures will consist of the average of three consecutive measurements taken approximately two minutes apart, and round to the nearest whole numbers. When possible blood pressure should be taken using the automated device provided to the site by the sponsor. It is encouraged that the blood pressure is always taken in the sitting position, however for patient who cannot sit, supine bolded pressure is acceptable. Documentation process: This form ist to be obtained 7 days post-randomization at Visit 1A

Palabras clave

Versiones (3)

1. 15/2/17 15/2/17 -
2. 20/2/17 20/2/17 -
3. 20/9/21 20/9/21 -

Subido en

15 de febrero de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia